AI tool to predict survival in people with glioma
Part of Cancer clinical trials.
This trial uses brain scan images (MRI) and tumor tissue tests to predict how long people with primary glioma may live. The goal is to see if the AI prediction can improve planning and care after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of a primary brain tumor called glioma (shown on MRI and confirmed by tissue biopsy)
- Your expected lifespan is more than 3 months
- You are scheduled to have tumor removal surgery (resection)
- You can sign an informed consent form
- You can provide enough tumor tissue for molecular (lab) testing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses AI to look at tumor tissue images to predict survival in people with glioma. If you qualify, your surgery tissue and imaging help train tools that may better estimate outcomes and guide care.
This trial uses an AI computer program to predict the molecular features of a primary brain tumor (glioma) by looking at tumor tissue images. Your results could help researchers better match glioma subtypes to more tailored care, using information obtained from the surgery sample.
This study uses brain MRI images and tumor tissue to predict the tumor’s molecular (cell-level) features in people with glioma. It may help doctors better understand glioma biology and plan care based on noninvasive imaging plus lab testing.
This trial uses artificial intelligence to analyze MRI scans from people diagnosed with a type of brain tumor called glioma. It aims to better understand the cancer from diagnosis through treatment, which could help guide future care.
This trial is for people with glioma who have tumor tissue or blood samples stored. It uses artificial intelligence to analyze these samples and find the best treatment. You might be eligible if you are at least 18 years old and have had a glioma diagnosis with tissue available for study.
This study is testing if artificial intelligence (AI) can look at microscope slides of your brain tumor tissue to guess its genetic makeup. It uses data already collected from your routine care, so there is no extra treatment or medicine involved.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.